Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features

MLA

Kishan, Amar U., et al. “Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.” JAMA Network Open, vol. 4, no. 7, July 2021, p. e2115312. EBSCOhost, https://doi.org/10.1001/jamanetworkopen.2021.15312.

APA

Kishan, A. U., Karnes, R. J., Romero, T., Wong, J. K., Motterle, G., Tosoian, J. J., Trock, B. J., Klein, E. A., Stish, B. J., Dess, R. T., Spratt, D. E., Pilar, A., Reddy, C., Levin-Epstein, R., Wedde, T. B., Lilleby, W. A., Fiano, R., Merrick, G. S., Stock, R. G., … Tilki, D. (2021). Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. JAMA Network Open, 4(7), e2115312. https://doi.org/10.1001/jamanetworkopen.2021.15312

Chicago

Kishan, Amar U., R. Jeffrey Karnes, Tahmineh Romero, Jessica K. Wong, Giovanni Motterle, Jeffrey J. Tosoian, Bruce J. Trock, et al. 2021. “Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.” JAMA Network Open 4 (7): e2115312. doi:10.1001/jamanetworkopen.2021.15312.